Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.67% | 342.92 | 1.2% | $619.87m | |
| GILD | Gilead Sciences, Inc. | -0.65% | 72.45 | 0.9% | $507.42m | |
| CELG | Celgene Corporation | -0.42% | 90.00 | 1.2% | $494.37m | |
| AMGN | Amgen Inc. | -0.06% | 197.31 | 1.2% | $485.07m | |
| ILMN | Illumina, Inc. | 0.28% | 326.79 | 3.5% | $374.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.41% | 372.74 | 2.6% | $314.50m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.90% | 174.50 | 1.9% | $207.20m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.26% | 116.30 | 2.0% | $187.07m | |
| A | Agilent Technologies, Inc. | 0.11% | 64.73 | 1.5% | $159.45m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.29% | 129.87 | 16.6% | $142.04m | |
| NKTR | Nektar Therapeutics | 0.45% | 60.30 | 5.6% | $126.86m | |
| BLUE | Bluebird Bio, Inc. | -0.60% | 157.05 | 14.6% | $120.84m | |
| EXAS | Exact Sciences Corporation | -0.72% | 48.49 | 25.3% | $117.97m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.09% | 98.90 | 4.4% | $116.26m | |
| INCY | Incyte Corporation | -0.23% | 68.64 | 2.5% | $111.47m |
Company Profile
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.